Your browser doesn't support javascript.
loading
Empagliflozin activates JAK2/STAT3 signaling and protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions.
Zhang, Fan; Cao, Xudong; Zhao, Chunhui; Chen, Li; Chen, Xiaolin.
Afiliação
  • Zhang F; Department of Cardiology, South University of Science and Technology Hospital, 6019 Liuxian Avenue, Xili, Nanshan District, Shenzhen, 518000, Guangdong, People's Republic of China.
  • Cao X; Department of Cardiology, South University of Science and Technology Hospital, 6019 Liuxian Avenue, Xili, Nanshan District, Shenzhen, 518000, Guangdong, People's Republic of China.
  • Zhao C; Department of Cardiology, South University of Science and Technology Hospital, 6019 Liuxian Avenue, Xili, Nanshan District, Shenzhen, 518000, Guangdong, People's Republic of China.
  • Chen L; Department of Cardiology, South University of Science and Technology Hospital, 6019 Liuxian Avenue, Xili, Nanshan District, Shenzhen, 518000, Guangdong, People's Republic of China.
  • Chen X; Department of Cardiology, South University of Science and Technology Hospital, 6019 Liuxian Avenue, Xili, Nanshan District, Shenzhen, 518000, Guangdong, People's Republic of China. biss7251@163.com.
J Thromb Thrombolysis ; 55(1): 116-125, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36396837
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miócitos Cardíacos / Hipóxia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Thromb Thrombolysis Assunto da revista: ANGIOLOGIA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miócitos Cardíacos / Hipóxia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Thromb Thrombolysis Assunto da revista: ANGIOLOGIA Ano de publicação: 2023 Tipo de documento: Article